Azacitidine and Rituximab-GDP Immunochemotherapy in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Clinical trial NCT03719989 · UNKNOWN
Trial details
- NCT number
- NCT03719989
- Sponsor
- Seoul National University Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-01
- Primary completion
- 2021-11-30
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.